Omabit raises $2M seed led by Bright Ventures to advance AI for scientific decision-making in drug development.

ELIQUENT Life Sciences, a global regulatory, quality and safety consulting firm, today announced its participation in ExoCordOA, a €13 million, five-year project funded by Horizon Europe and ...

Drug development is essentially a long, expensive bet: 90% of drugs fail during clinical trials, goes one of the life science industry’s most oft-quoted statistics. But new ways of identifying and ...

The first year of life is a period of rapid brain development. Your baby's brain is constantly forming and strengthening ...

The Food and Drug Administration (FDA) defines regulatory science as the science of developing new tools, standards, and approaches to assess the safety, effectiveness, quality, toxicity, public ...

Roundtable discussion on “Bridging the Divide” co-hosted by Devex and Microsoft in Davos. Photo by: Microsoft Data science has the potential to drive sustainable development in least developed ...

Addressing the complexity of FSP and FSO outsourcing models, this new solution, powered by Science Exchange's supplier orchestration platform, modernizes clinical supplier collaboration and budget ...

To promote the crucial roles of open science and accelerate progress towards the Sustainable Development Goals (SDGs), measures must be taken to achieve equity and inclusion, reform academic ...

We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines: You have to credit our authors. You ...

Chancellor John Healey has announced money to support major expansion ...